Our Three Pillars
The history of the company, expressed
in three key areas
We develop and manufacture quality products with added human value. We are committed to excellence and to continuous improvement.
Our multidisciplinary team, technology and the applied science are the foundations on which we design the quality of our products. This level of quality starts with product definition and development and continues all along the production and life.
We are a team specialized in different academic disciplines. Half of our workforce works in research and development, quality control, production and engineering. We are deeply committed to include and develop young talents by promoting their improvement in technical and interpersonal skills.
Our research and development and quality control laboratories, and the manufacturing plant are equipped with state-of-the-art technologies and operate using the highest standards of quality and efficiency.
Our manufacturing plant is located at Parque Industrial Pilar, 60 km away from Buenos Aires and required a 14 million dollar investment.
Situated in a 6 hectare lot and with a 5600 square meter surface area, the plant is equipped with the most advanced technology devoted to the manufacturing of tablets and capsules, specifically to complex products with a high added value for the treatment of HIV-AIDS and neurodegenerative and cardiovascular diseases.
The plant capacity is 100 million tablets and capsules per year. As Laboratorios Richmond continues penetrating new markets, the plant was designed to include new production units and increase its capacity four times.
It is equipped with the latest technologies and complies with the international standards required for the manufacturing of pharmaceutical products, following PIC, EMA (European Union) standards and is also ready to certify with the US FDA. The plant was qualified according to quality risk management criteria and has an ISO 9001:2008 certification. To consolidate our international presence, the plant re-certified for good environmental practices according to ISO 9001 and 14001.
Our aim is that health care is not a privilege. Our actions are focused on patients and their possibilities to access new treatments.
Consequently, we focus on launching the first generic drug and biosimilar products, develop products enabling treatment adherence and providing innovative therapies through licenses. Thus, our actions contribute to balancing health care costs.
Click here to see the most recent products launched
Previd, first argentinian generic drug to treat HIV
A generic drug is interchangeable with the original product because it has the same active ingredient, the same route of administration, the same pharmaceutical form and the same behavior. In other words, it is identical to the original drug in terms of safety and efficacy, it behaves in the same manner and has the same indication. Like the original product, generic drugs must comply with the same standards of quality and control during production. The competent National Health Authority is the body determining the product final approval before authorizing the product sale in the market.
The existence of generic drugs opens the possibility for competition, thus reducing the cost of the pharmaceutical products in the market and therefore making the access to medication easier to the whole of the population. Additionally, a generic drug exerts a control power to prevent monopolistic practices. In this way, innovative laboratories are pushed to perform new research. If innovative laboratories kept their exclusive rights over their patents indefinitely, they would not need to make Research and Development efforts to remain in the market.
A treatment is effective not only because of the quality of the medication but also because of the adherence to the treatment, that is, if the patient takes the medication as prescribed. On many occasions this is not achieved due to the difficulties caused to the patient (for example, when a treatment requires multiple tablets taken at different times).
Richmond’s focus is the patient; therefore, we develop products and alternatives which ease the access to the treatment.
Some examples are single fixed dose combinations (Trivenz®), combinations with fixed dose as a part of a treatment (Virontar® N) and multi-dose tablets (Mystika®). In most of the cases a user-friendly packaging was designed to transport the medication and take it when needed, thus ensuring quality.
Renowned European pharmaceutical companies, owners of original pharmaceutical products granted Laboratorios Richmond licenses to sell their products exclusively in Argentina. These are innovative and unique treatments which boost our company’s portfolio.
EVER Neuro Pharma GmbH, Austria, for its products RENACENZ® and TACHYBEN®
Ferrer Internacional, S.A., Spain, for its products OMACOR® and TRINOMIA®
Pharmacosmos A/S, Denmark, for its product MONOFER®
We reaffirm the efficient performance of our organization along the time in economic, social and environmental areas, which provides sustainability to our history of more than 80 years.
Our sustainability is based on our commitment to our work team, the environment, our community, to health care and to our way of doing business.
Check our latest Corporate Social Responsibility Balance Sheet
Our Work Team
Our team is our most valuable asset. Our actions are governed by our Commitment to our Personnel. Being aligned with this work culture is essential in the composition of our team. Because we are what we are, because diversity makes us better. Our growth as a company brings about the growth of the members of our team and vice versa.
Commitment to our Personnel
- At Laboratorios Richmond, we reaffirm our commitment to create a fair, pleasant and respectful work environment.
- Our policy is to enhance and encourage the respect for the individual behavior and also to work showing trust and honesty geared to achieve a good interpersonal communication.
- Each member of our work team has the right to work free from any form of harassment.
- We do not allow any malicious statements or discrimination based on religion, race, color, gender, sexual orientation, nationality or ethnic origin, age, or physical or mental disability.
We are aware of our debt to our Planet, consequently for us “taking care of the environment is taking care of our home”.
We work using clean practices, we treat our waste, we do not release emissions and we developed processes minimizing the environmental impact.
Our ISO 14001 is proof of our environmental management.
Since October 2016, the Argentine certification body IRAM, certifies that in Laboratorios Richmond we work under an Environmental Management System that meets the requirements of ISO-IRAM 14001: 2004, according to Registration Certificate No. 14000-815, whose scope en: Design, development, logistics, management and manufacture of medicinal specialties in the facilities of Pilar Plant, Pilar Industrial Park, Prov of Buenos Aires, Argentina.
At the same time, said certification has an international scope validated by Registration No.: AR-ES-815, granted by IQNET (The International Certification Network).
The validity of the certificate is 2 years renewable each year.
We take care of our “Grand Homeland” (our Planet) and also our small homeland, the community where we belong.
Consequently we carry out various actions contributing to social development, such as:
- Research sponsorship
- Scholarships to university students
- Internship programs
- Professional practices for technical schools
How We Do Things
Richmond quality is our non-negotiable seal. Our quality chain goes beyond us: it starts in our suppliers and ends in the products consumed by a patient. To that end, we not only certify our Quality System, but we also keep strategic alliances.
One of the key pillars of pharmaceutical drug manufacturing is the Quality Policy enforced by Laboratorios Richmond. This policy was set as a corporate standard and its application ranges from the development phase, through each one of our pharmaceutical products to the permanent orientation and counseling service given to patients, including addressing patients’ queries.
We comply with the most rigorous international standards in force both for the development and the manufacturing of our pharmaceutical products. This quality risk management guarantees the safety and efficacy of all our products. Our ISO 9001 certification endorses our quality system.